Welcome to the Steed lab

Our lab investigates the host response to pathogenic infections, specifically the mechanisms underlying antiviral innate immune responses.  We are also focused on the role of the microbiota in the establishment and maintenance of antiviral immunity.

Group photo of the lab's team members.
2024 Steed lab group photo

Interested in joining our team?

Please email Ashley Steed with any questions.

Proudly funded by…

Children’s Discovery Institute

NIH-NIAID

Burroughs Wellcome Fund

Ashley Steed, MD, PhD

Principal investigator

Ashley Steed is a physician-scientist and Assistant Professor of Pediatrics in the Division of Critical Care Medicine at Washington University School of Medicine. She received her bachelor’s degree in biology from Duke University. Thereafter she matriculated in the NIH-sponsored Medical Scientist Training Program at Washington University for medical and graduate school. Her graduate work in immunology focused on understanding host responses to infections, and specifically, elucidated the role of interferon gamma in suppression of viral reactivation from latency. Then she completed clinical training with a residency and chief-residency in pediatrics and subspecialty training in pediatric critical care medicine. She joined the faculty in 2016.
 
Steed’s research investigates the role of the microbiota in the establishment and maintenance of antiviral immunity. She was a fellow in the Pediatric Scientist Development Program and one of the first trainees in the Oliver Langenberg Physician-Scientist Training Program at Washington University. Her work demonstrated that specific bacteria and associated metabolites enhance innate immunity and afford protection in animal models of influenza infection. Currently, she aims to define the cellular and molecular mechanisms by which age and microbial dysbiosis impacts antiviral immunity. She is currently funded by the Washington University Department of Pediatrics, the Children’s Discovery Institute, NIH-NIAID and the Burroughs Wellcome Fund.